Watson appoints new VP global investor relations

PARSIPPANY, N.J. — Generic drug maker Watson Pharmaceuticals has appointed Lisa DeFrancesco as its VP global investor relations, the company said Friday.



Succeeding Patricia Eisenhaur, who will leave the company on June 1, DeFrancesco will report directly to chief communications officer Charles Mayr. She will be responsible for investor relations programs and serve as the company's principal spokeswoman and point of contact with the analyst and investment community.



DeFrancesco began working for Watson in 2009 as manager of investor relations, receiving a promotion to director of investor relations in 2010. She previously worked for companies like Virgin Mobile USA, Realogy, Cendant and Horizon Blue Cross/Blue Shield.

Interested in this topic? Sign up for our weekly DSN Collaborative Care e-newsletter.